Design of substituted tetrahydrofuran derivatives for HIV-1 protease inhibitors: synthesis, biological evaluation, and X-ray structural studies.
Ghosh, A.K., Lee, D., Sharma, A., Johnson, M.E., Ghosh, A.K., Wang, Y.F., Agniswamy, J., Amano, M., Hattori, S.I., Weber, I.T., Mitsuya, H.(2024) Org Biomol Chem 22: 7354-7372
- PubMed: 38973505 
- DOI: https://doi.org/10.1039/d4ob00506f
- Primary Citation of Related Structures:  
9B2H - PubMed Abstract: 
Substituted tetrahydrofuran derivatives were designed and synthesized to serve as the P2 ligand for a series of potent HIV-1 protease inhibitors. Both enantiomers of the tetrahydrofuran derivatives were synthesized stereoselectivity in optically active forms using lipase-PS catalyzed enzymatic resolution as the key step. These tetrahydrofuran derivatives are designed to promote hydrogen bonding and van der Waals interactions with the backbone atoms in the S2 subsite of the HIV-1 protease active site. Several inhibitors displayed very potent HIV-1 protease inhibitory activity. A high-resolution X-ray crystal structure of an inhibitor-bound HIV-1 protease provided important insight into the ligand binding site interactions in the active site.
Organizational Affiliation: 
Department of Chemistry, Purdue University, 560 Oval Drive, West Lafayette, IN 47907, USA. akghosh@purdue.edu.